We reviewed new psoriatic arthritis approvals as well as data readouts from head-to-head trials and milestone data in IgG4-related disease.
|Slideshows|March 15, 2018
New-Onset Inflammatory Back Pain: What Lies Ahead?
Spondyloarthritis is not the inevitable destination.
Advertisement
Reference1. Wang R, Crowson CS, Wright K, Ward MM. Clinical evolution of patients with new-onset inflammatory back pain: a population-based cohort study. Arthritis Rheumatol. 2018 Feb 22. doi: 10.1002/art.40460. [Epub ahead of print]
Advertisement
Related to this article
Key changes in the 2026 ACR/SAA/SPARTAN guideline update elevate JAK inhibitors to a strong recommendation and introduce nociplastic pain guidance.
Advertisement
Advertisement